Showing 1021-1030 of 9918 results for "".
DermwireTV: DermaRite Issues Recall for Several Hand Soaps
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-dermarite-issues-recall-for-several-hand-soaps/37113/In this episode, new research shows switching between interclass biologics may be safe and effective for psoriasis patients; DermaRite recalls 4 skin care products over contamination concerns; and awareness grows for generalized pustular psoriasis through a new global awareness campaign.Remembering Dr. Robert Sidbury
https://practicaldermatology.com/issues/august-2025/remembering-dr-robert-sidbury/36712/The dermatology community was shaken last month by the sudden passing of Robert Sidbury, MD, MPH, at 61. Dr. Sidbury was Chief of Dermatology at Seattle Children’s Hospital, Professor in the University of Washington Department of Pediatrics, and a former President of the Society for Pediatric DermatScurvy Following Gastric Bypass
https://practicaldermatology.com/issues/august-2025/scurvy-following-gastric-bypass/36701/This report highlights a unique case of scurvy presentation following gastric bypass surgery. A 39-year-old female presented for outpatient dermatology follow-up for a rash that had been present for several months, affecting the buttocks, extremities, and trunk.DWTV Extra: DermLink Scholars Founder Dr. Kelly Frasier
https://practicaldermatology.com/series/dermwire-tv/DWTV-Extra-DermLink-Scholars-Founder-Dr-Kelly-Frasier/36554/DermLink Scholars Founder and CEO Kelly Frasier, DO, MS, CRC, and Alina G. Bridges, DO, FAAD, discuss the organization and its inaugural virtual conference Saturday, August 2. For more information, go to dermlinkscholars.com.DermwireTV: Pharma Partnership Boosts Spesolimab, Plus More
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pharma-partnership-boosts-spesolimab-plus-more/36519/In this episode of Dermwire TV, two pharma leaders partner to commercialize SPEVIGO for patients with generalized pustular psoriasis; interest in red light devices is up; and experts take a look at what’s new in psoriasis treatments on the Practical Dermatology Podcast.Evaluating Lebrikizumab in Pigmented Skin
https://practicaldermatology.com/series/updates-atopic-dermatitis/evaluating-lebrikizumab-in-pigmented-skin/36490/Andrew Alexis, MD, MPH, discusses new data presented at the Revolutionizing Atopic Dermatitis (RAD) Conference from the phase 3b Admirable trial, the first dedicated study for evaluating the efficacy and safety of Lilly's FDA-approved medicine in adult and adolescent patients with pigmented skin andNemluvio Shows Efficacy in AD
https://practicaldermatology.com/series/dermwire-tv/nemluvio-shows-efficacy-in-ad/36134/In this episode of DermwireTV, Nemluvio (nemolizumab) showed efficacy in atopic dermatitis in recent studies; strontium cream helps manage pruritus in hidradenitis suppurativa (HS); and Lisa Swanson and Peter Lio get viewers up to date on dupilumab’s effectiveness at halting atopic march.Rosacea Comorbidities and Skincare with Energy-Based Devices
https://practicaldermatology.com/programs/practical-dermatology/rosacea-comorbidities-and-skincare-with-energy-based-devices/35895/Ted Lain, MD, MBA, discusses the gut-skin connection as it relates to rosacea, as well as skincare with energy-based devices, at Music City SCALE 2025.Seborrheic Dermatitis Approaches and Stopping Biologic Treatment for Atopic Dermatitis
https://practicaldermatology.com/conferences/scale-2025/seborrheic-dermatitis-approaches-and-stopping-biologic-treatment-for-atopic-dermatitis/35896/Naiem T. Issa, MD, PhD, talks at Music City SCALE 2025 about how to approach seborrheic dermatitis, as well as what happens to atopic dermatitis patients after ending biologic treatments.Rosacea Treatment Options and Strategies
https://practicaldermatology.com/programs/practical-dermatology/rosacea-treatment-options-and-strategies/35893/Joel L. Cohen, MD, FAAD, and Hilary Baldwin, MD, talk at Music City SCALE 2025 about the latest treatment options for rosacea and strategies for getting patient buy-in.